Skip to main content

Advertisement

Table 1 Participant Demographics (Safety Population)

From: Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

     LDX Dose
Category   Age Group Statistic 30 mg/d 50 mg/d 70 mg/d All doses
Age (y)   6-9 n 27 15 6 48
    Mean (SD) 8.5 (0.75) 8.5 (0.74) 8.0 (0.89) 8.5 (0.77)
   10-12 n 31 35 15 81
    Mean (SD) 10.9 (0.96) 10.9 (0.73) 11.4 (1.12) 11.0 (0.91)
Sex* Male 6-9 n (%) 18 (66.7) 13 (86.7) 6 (100) 37 (77.1)
  Female   n (%) 9 (33.3) 2 (13.3) 0 11 (22.9)
  Male 10-12 n (%) 26 (83.9) 24 (68.6) 11 (73.3) 61 (75.3)
  Female   n (%) 5 (16.1) 11 (31.4) 4 (26.7) 20 (24.7)
Weight (lb)   6-9 n 27 15 6 48
    Mean (SD) 62.2 (8.78) 65.0 (13.75) 53.1 (2.50) 61.9 (10.62)
   10-12 n 31 35 15 81
    Mean (SD) 78.9 (16.36) 79.0 (18.64) 80.7 (17.29) 79.3 (17.34)
Height (in)   6-9 n 27 15 6 48
    Mean (SD) 51.2 (2.30) 52.1 (2.29) 49.3 (2.04) 51.3 (2.38)
   10-12 n 31 35 15 81
    Mean (SD) 56.2 (2.84) 56.2 (3.08) 57.3 (2.79) 56.4 (2.93)
Body mass index (kg/m2)   6-9 n 27 15 6 48
    Mean (SD) 16.6 (1.44) 16.7 (2.38) 15.4 (1.28) 16.5 (1.78)
   10-12 n 31 35 15 81
    Mean (SD) 17.4 (2.45) 17.4 (2.67) 17.2 (2.55) 17.4 (2.53)
  1. SD: standard deviation.
  2. *Percentages are based on number of participants in the age group of the dose classification.